Serum IL-6: A potential biomarker of mortality among SARS-CoV-2 infected patients in Mexico

•High number of deaths due to COVID-19 have been found in Mexican patients.•IL-6 can be used as biomarker of mortality in COVID-19 patients form Mexico.•IL-6 is correlated to high levels of CRP, LDH, procaciltonin and lymphopenia. The first case of SARS-CoV-2 in Mexico was reported in February 2020,...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cytokine (Philadelphia, Pa.) Pa.), 2021-07, Vol.143, p.155543-155543, Article 155543
Hauptverfasser:	Avila-Nava, Azalia, Cortes-Telles, Arturo, Torres-Erazo, Darwin, López-Romero, Stephanie, Chim Aké, Rodolfo, Gutiérrez Solis, Ana Ligia
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Age Factors Aged Biomarkers - blood C-Reactive Protein - analysis COVID-19 COVID-19 - blood COVID-19 - mortality COVID-19 - pathology Cytokine Release Syndrome - blood Cytokine Release Syndrome - mortality Cytokine Release Syndrome - pathology Cytokine storm Female Humans Immunoassay Inflammatory cytokines Interleukin 6 Interleukin-6 - blood Lymphocyte Count Male Mexico Middle Aged Mortality Prognosis SARS-CoV-2 SARS-CoV-2 - immunology Severity of Illness Index Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!